发明名称 |
Combination therapy comprising a bisphosphonate and a hmg-coa reductase inhibitor |
摘要 |
A pharmaceutical composition for treatment of malignancies, in particular multiple myeloma (MM), comprises in combination a bisphosphonate, e.g. zoledronic acid or a salt or ester, and an HMG-CoA reductase inhibitor for simultaneous, sequential or separate use. Also provided is a method of treating a patient suffering from a malignant disease comprising administering to the patient an effective amount of a bisphosphonate and an effective amount of an HMG-CoA reductase inhibitor.
|
申请公布号 |
US2006234985(A1) |
申请公布日期 |
2006.10.19 |
申请号 |
US20030526282 |
申请日期 |
2003.09.08 |
申请人 |
BAULCH-BROWN CINDY M;SPENCER ANDREW |
发明人 |
BAULCH-BROWN CINDY M.;SPENCER ANDREW |
分类号 |
A61K31/401;A61K31/22;A61K31/366;A61K31/404;A61K31/405;A61K31/66;A61K31/663;A61K31/67;A61K45/06;A61P35/00 |
主分类号 |
A61K31/401 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|